Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Stock in Focus After Reverse Stock Split

May 17, 2022

Clinical-stage biopharmaceutical company, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), announced that it will effect a 1-for-32 reverse stock split of its outstanding common stock, on May 16, 2022. Trading Data On Monday, TNXP stock slumped 31.36% to $0.0904 with more than 104.06 million shares, compared to its average volume of 31.04 million shares. The stock moved within a range of $0.0881 – 0.1337 after opening trade at $0.1337. The reverse stock…

Read More >>

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Stock Gains Momentum: Jumps 16% In a Week

March 22, 2022

In the past week, there has been considerable activity in the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) stock and as a consequence, it has managed to clock gains of as much as 16%. In light of such strong gains, the stock is likely to come into focus among investors in the coming days. Trading Data On Monday, TNXP stock ended up by 1.04% to $0.2425 with more than 31.96 million shares…

Read More >>